Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

BACKGROUND: Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy are unknown. METHODS: An observational study was carried out on the Italian MASTER...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Infect Dis
Auteurs principaux: Postorino, Maria Concetta, Prosperi, Mattia, Focà, Emanuele, Quiros-Roldan, Eugenia, Di Filippo, Elisa, Maggiolo, Franco, Borghetti, Alberto, Ladisa, Nicoletta, Di Pietro, Massimo, Gori, Andrea, Sighinolfi, Laura, Pan, Angelo, Mazzini, Nicola, Torti, Carlo
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5353877/
https://ncbi.nlm.nih.gov/pubmed/28298195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2322-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires